Peptide Decoding
New?New to peptides?Start here →
Decoding

Oligopeptide-1 (EGF)_Dosage, benefits & legal status

Also known as EGF, epidermal growth factor, sh-Oligopeptide-1, rh-Oligopeptide-1, human EGF

Published August 24, 2026 · Updated October 4, 2026

Epidermal growth factor under a cosmetic name, and the only real protein on this shelf.

Repair and barrierCosmetic peptide (topical)Cosmetic
DoseSerum, per product
FrequencyDaily
RouteOn the skin (topical)
StatusCosmetic ingredient
CycledNot cycled

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Oligopeptide-1 (EGF)?

Plain language first. The technical label stays, but it never stands alone.

Overview

Epidermal growth factor sold under a cosmetic name. The healing research behind it is real and was done on broken skin, which is not the same as a serum on an intact face.

The technical version

Oligopeptide-1, the INCI designation for recombinant human epidermal growth factor, a 53-residue protein signaling through the EGF receptor to drive keratinocyte proliferation and migration. Clinical evidence is concentrated in wound healing rather than in cosmetic use on intact skin.

What it's used for

A topical growth factor used in skincare for repair, barrier support and post-procedure recovery.

02

How does Oligopeptide-1 (EGF) work?

What it does in the body, and where.

EGF is not a cosmetic invention. It is a signaling protein with a Nobel Prize behind it and a long wound-healing literature.

  1. 01
    It tells skin cells to divide
    EGF binds its own receptor on keratinocytes and triggers proliferation and migration, which is exactly what closing a wound requires.
  2. 02
    Size is the whole problem in a cosmetic
    At 53 amino acids this is a protein, not a peptide. Intact skin is built to keep molecules this large out, so a great deal depends on the delivery system and on whether the skin barrier is broken.
  3. 03
    The growth signal cuts both ways
    Telling cells to divide faster is useful in a healing wound. The same instruction is the reason caution is warranted with any active skin cancer or undiagnosed lesion, and why this is the one ingredient in the cosmetic category where that caveat is not boilerplate.
Where it acts
Skin

Where this compound is thought to act.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Skin repair and barrier support, applied to the skinSupplement or cosmetic
  • Recovery after cosmetic procedures such as lasers and microneedlingEarly research
  • Wound healing, which is where the underlying research comes fromClinical use
  • Added to lash and hair serums to extend the growing phasenone

The published record

Research index

97,827

Papers and trials about Oligopeptide-1 (EGF)

325 papers tagged human · 230 not reviews or lab · 50 clinical trial publications

16 registered trials · none with posted results

Furthest stage reached: Phase 3, completed, no results posted

Compare this against the whole library →

In animals79
In the lab14
Reviews99
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 499 papers and 16 trials indexed in detail.

Oligopeptide-1 (EGF) vial rendering
Compound field notes

At a glance

Four things to know about Oligopeptide-1 (EGF)

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not measured, and not the right question

04

How much, and do you cycle it?

The range, and whether you take breaks.

Serum, per product, daily. Not cycled Community practice

Used daily as part of a routine. The effect depends on continued use and returns to baseline when you stop, so there is nothing to cycle off.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not measured, and not the right questionNo figure

This is a topical cosmetic ingredient. A blood half-life measures how fast something leaves the bloodstream, and these are not intended to reach it in meaningful amounts. What matters for a topical is how much penetrates the skin and how long it stays in the tissue, which is a different measurement and one that is rarely published.

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

Oligopeptide-1 (EGF) is not injected

It is taken on the skin (topical). Applied as a topical product at the concentration the manufacturer sets. There is no injected dose.

Cost per month
—
Cost per dose
—
Typical dose
0.1 mcg–0.5 mcg / formulationCommunity practice
07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Oligopeptide-1 (EGF) ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

Growth factors are large and fragile. Heat and light degrade them, which is why products carrying EGF are usually packaged airless or opaque and why a clear jar sitting on a windowsill is a reason to doubt what is left in it.

Solubility, computed: 30% charged residues, 42% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • A known allergy to this ingredient or to others in the same product
  • Broken, cracked, or actively irritated skin
  • Active skin cancer, or any lesion that has not been diagnosed, because this instructs cells to divide
  • A history of skin cancer, without asking a dermatologist first
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • A rash that spreads beyond where you applied it
  • Swelling of the face, lips, or eyelids, or any trouble breathing
  • Burning that does not settle after rinsing it off
  • Any mole or lesion that changes in size, shape or color
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Generally well tolerated on the skin.
  • It is a growth signal, so caution applies with any undiagnosed skin lesion.
  • Beyond the above, unknown. There is no reliable human data on what this compound commonly causes

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Oligopeptide-1 (EGF) approved?

And where the numbers on this page come from.

Not as a medicine. Oligopeptide-1 (EGF) is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

  • Approval status
    CosmeticSold without a prescription as an ingredient in cosmetics, such as skincare and hair products. The FDA does not approve cosmetics before they are sold, and being easy to buy says nothing about whether it works.
  • Route
    On the skin (topical)
  • Checked
    24 August 2026
  • Dose
    From the concentration range manufacturers formulate at. This is a product strength, not a dose set by a regulator or a trial.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

Regulated as a cosmetic ingredient, not a drug. Cosmetic ingredients are not reviewed for effectiveness before sale in the US, so a product may legally claim an appearance benefit without a trial behind it.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 515 records are indexed. Browse the records